Cotización Structure Therapeutics - GPCR

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

34.10

Postura de Compra

34.08

Postura de Venta

34.16

Volume Operado de la Acción

382,710

33.1301 Rango del Día 34.19

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

1.953B

Precio Anterior

33.94

Precio de Apertura

33.89

Hora

34.08

Última hora de negociación

13:01:23

Volumen financiero

US$ 12,947,772

Precio Promedio Ponderado

33.8318

Volumen promedio (3 m)

Acciones en circulación

57,260,673

Rendimiento del Dividendo

Ratio Precio/Utilidad

0.00

Beneficio por acción (BPA)

turnover

Beneficio neto

-89.62M

Structure Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing oral treatments for chronic metabolic and pulmonary conditions. It develops oral small molecule therapeutics for the treatment of various diseases, including those impactin... Structure Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing oral treatments for chronic metabolic and pulmonary conditions. It develops oral small molecule therapeutics for the treatment of various diseases, including those impacting the metabolic, cardiovascular, and pulmonary systems. Its initial focus is on G-protein-coupled receptors as a therapeutic target class. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor for the treatment of type-2 diabetes mellitus and obesity. It is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases. Specifically, it is advancing ANPA-0073, its biased agonist, targeting the apelin receptor. It is also developing LTSE-2578, an investigational oral small molecule LPA1R antagonist for the treatment of idiopathic pulmonary fibrosis. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.structuretx.com

Sede

Grand Cayman, Cym

Fundado

Structure Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GPCR. The last closing price for Structure Therapeutics was US$33.94. Over the last year, Structure Therapeutics shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Structure Therapeutics currently has 57,260,673 shares in issue. The market capitalisation of Structure Therapeutics is US$1.94 billion.

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights

First patients dosed in Phase 2b ACCESS study of GSBR-1290 for obesity Oral small molecule amylin receptor agonist development candidate expected to be selected by the end of 2024 Strong...

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity

Phase 2b ACCESS study designed to evaluate multiple doses up to 120 mg of GSBR-1290 over 36 weeks Comprehensive development program also includes Phase 2 ACCESS II study to evaluate even higher...

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer

SAN FRANCISCO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics...

Form 8-K - Current report

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CTNTCheetah Net Supply Chain Service Inc	US$ 5.318 (184.39%)	107.59M
ZJKZJK Industrial Company Ltd	US$ 14.37 (126.66%)	20.59M
GWAVGreenwave Technology Solutions Inc	US$ 0.6041 (65.51%)	404.06M
JANXJanux Therapeutics Inc	US$ 62.10 (54.55%)	5.33M
JYDJayud Global Logistics Ltd	US$ 1.03 (53.71%)	9.42M
REVBRevelation Biosciences Inc	US$ 0.5649 (-40.53%)	3.88M
OMEXOdyssey Marine Exploration Inc	US$ 0.48335 (-35.14%)	3.55M
STSSSharps Technology Inc	US$ 2.2308 (-33.48%)	380.92k
GELSGelteq Ltd	US$ 2.6491 (-30.66%)	225.23k
MOBXMobix Labs Inc	US$ 1.0022 (-28.42%)	1.23M
GWAVGreenwave Technology Solutions Inc	US$ 0.6035 (65.34%)	404.24M
SMCISuper Micro Computer Inc	US$ 41.22 (-1.86%)	171.03M
CTNTCheetah Net Supply Chain Service Inc	US$ 5.3101 (183.96%)	109.14M
CHRSCoherus BioSciences Inc	US$ 1.785 (30.29%)	104.76M
NVDANVIDIA Corporation	US$ 139.3338 (0.51%)	102.78M